Request Appointment
161 Fort Washington AveHerbert Irving Pavilion 9th FloorNew York, NY 10032
Overview of Dr. Wei
Dr. Alexander Wei is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Hawaii, John A. Burns School of Medicine and has been in practice 8 years. He is one of 119 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 384 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 10 publications and over 150 citings.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2020 - 2023- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2017 - 2020
University of Hawaii, John A. Burns School of MedicineClass of 2017
University of RochesterMS, Immunology, 2012 - 2013
Certifications & Licensure
FL State Medical License 2024 - Present
NY State Medical License Active through 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Joseph N Muschel Housestaff Award 2020
Clinical Trials
- APX005M and Doxorubicin in Advanced Sarcoma Start of enrollment: 2019 Mar 20
- Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma Start of enrollment: 2022 Apr 07
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Start of enrollment: 2016 Mar 14
Publications & Presentations
PubMed
- Novel Strategies and Therapeutic Advances for Bladder Cancer.Matthew I Ehrlich, Robert D Fox, Karie D Runcie, Mark N Stein, Alexander Z Wei
Cancers. 2025-06-20 - Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.Michael A Liu, Rohit Raghunathan, Karie Runcie, Shikun Wang, Jason D Wright
JCO Oncology Practice. 2025-06-12 - Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surv...Benjamin I Joffe, John R Christin, Clémentine Le Coz, Srinath-Reddi Pingle, Alexander Z Wei
Current Urology Reports. 2025-04-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
